Colossal Biosciences
Signal active
Investment Firm
Overview
Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through innovative science and technology.
Highlights
Founded
2021
Industry
Biotechnology
Employees
101-250
Investment
1
Lead Investment
0
Exits
undefined
Stages
Seed
Investor Type
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Colossal Biosciences, established in 2021 and headquartered in United States, North America., specializes in Seed investments across Financial Services, Venture Capital, Angel Investment, Finance. Their recent investments include Builders VC, Climate Capital, Animal Capital. The highest investment round they participated in was $378.0M. Among their most notable exits are Builders VC and Climate Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
N/A
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 17, 2024 | Breaking | - | 10.5M |
Exits
0
Funding Timeline
Funding rounds
1
Investors
37
Funds
0
Funding Rounds
1
Colossal Biosciences has raised 1 rounds. Their latest funding was raised on Apr 17, 2024 from a Seed Round - Breaking round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 17, 2024 | Seed Round - Breaking | - | 10.5M | - |
Investors
39
Colossal Biosciences is funded by 39 investor(s). Animoca Brands and In-Q-Tel Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Bold Capital Partners | No | Series B - Colossal Biosciences | 162.6M |
In-Q-Tel | No | Series B - Colossal Biosciences | 162.6M |
Animoca Brands | No | Series B - Colossal Biosciences | 162.6M |
| - | No | Venture Round - Colossal Biosciences | 10.5M |
Bold Capital Partners
Animoca BrandsFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.